SK286437B6 - Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie - Google Patents
Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie Download PDFInfo
- Publication number
- SK286437B6 SK286437B6 SK1543-99A SK154399A SK286437B6 SK 286437 B6 SK286437 B6 SK 286437B6 SK 154399 A SK154399 A SK 154399A SK 286437 B6 SK286437 B6 SK 286437B6
- Authority
- SK
- Slovakia
- Prior art keywords
- composition
- gel
- alginate
- protein
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85797397A | 1997-05-16 | 1997-05-16 | |
US91290297A | 1997-08-15 | 1997-08-15 | |
PCT/US1998/010013 WO1998051348A2 (en) | 1997-05-16 | 1998-05-18 | Sustained-release delayed gels |
Publications (2)
Publication Number | Publication Date |
---|---|
SK154399A3 SK154399A3 (en) | 2000-07-11 |
SK286437B6 true SK286437B6 (sk) | 2008-10-07 |
Family
ID=27127437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1543-99A SK286437B6 (sk) | 1997-05-16 | 1998-05-18 | Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0981374B1 (ja) |
JP (1) | JP2001525826A (ja) |
KR (1) | KR20010012374A (ja) |
AU (1) | AU7491898A (ja) |
BG (1) | BG64860B1 (ja) |
BR (1) | BR9809117A (ja) |
CA (1) | CA2289196C (ja) |
CZ (1) | CZ299180B6 (ja) |
DE (1) | DE69838750T2 (ja) |
EA (1) | EA199901013A1 (ja) |
ES (1) | ES2294814T3 (ja) |
HU (1) | HUP0003393A3 (ja) |
IL (1) | IL132814A0 (ja) |
NO (1) | NO995591D0 (ja) |
PL (1) | PL199565B1 (ja) |
SK (1) | SK286437B6 (ja) |
WO (1) | WO1998051348A2 (ja) |
YU (1) | YU58599A (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003200609B2 (en) * | 1998-05-18 | 2006-02-23 | Amgen Inc. | Biodegradable sustained-release alginate gels |
US6432449B1 (en) * | 1998-05-18 | 2002-08-13 | Amgen Inc. | Biodegradable sustained-release alginate gels |
JP2000256216A (ja) * | 1999-03-04 | 2000-09-19 | Meiji Milk Prod Co Ltd | ゲル組成物 |
US7651703B2 (en) | 1999-10-15 | 2010-01-26 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
US7582311B1 (en) | 1999-10-15 | 2009-09-01 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
CA2396431A1 (en) * | 1999-11-29 | 2001-05-31 | Advanced Research And Technology Institute, Inc. | Sustained percutaneous delivery of a biologically active substance |
FR2823119B1 (fr) * | 2001-04-05 | 2004-02-20 | Seppic Sa | Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant |
EP1562546A1 (en) * | 2002-10-25 | 2005-08-17 | Pfizer Products Inc. | Depot formulations of arylheterocyclic active agents in the form of a suspension |
DK3081215T3 (da) * | 2005-05-23 | 2020-04-27 | Natural Alternatives Int Inc | Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin |
US20070202186A1 (en) * | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
JP5107585B2 (ja) * | 2007-01-29 | 2012-12-26 | 株式会社 メドレックス | 低温充填ゼリー組成物とその製造方法 |
EP1985286A1 (en) * | 2007-04-24 | 2008-10-29 | Biocompatibles UK Limited | Microspheres for treatment of brain tumours |
JP5996544B2 (ja) | 2010-10-15 | 2016-09-21 | クリアサイド・バイオメディカル・インコーポレーテッドClearside Biomedical Incorporated | 眼球アクセス用装置 |
MX2015005839A (es) | 2012-11-08 | 2015-12-17 | Clearside Biomedical Inc | Metodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos. |
CN110302004B (zh) | 2013-05-03 | 2023-04-28 | 科尼尔赛德生物医学公司 | 用于眼部注射的设备和方法 |
US10010447B2 (en) | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
MX2016017028A (es) | 2014-06-20 | 2017-08-07 | Clearside Biomedical Inc | Canula de diametro variable y metodos para el control de la profundidad de insercion para administracion de medicamentos. |
WO2017139375A1 (en) | 2016-02-10 | 2017-08-17 | Clearside Biomedical, Inc. | Ocular injection kit, packaging, and methods of use |
CA3062845A1 (en) | 2016-05-02 | 2017-11-09 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
US10973681B2 (en) | 2016-08-12 | 2021-04-13 | Clearside Biomedical, Inc. | Devices and methods for adjusting the insertion depth of a needle for medicament delivery |
EP3644729A1 (en) * | 2018-06-04 | 2020-05-06 | Spermvital AS | Functionalized kit for preparing hydrogels |
EP3878476A4 (en) * | 2018-11-06 | 2022-07-27 | National Cancer Center | ALGINIC ACID INJECTABLE HYDROGEL SYSTEM |
CN113423386A (zh) * | 2019-10-01 | 2021-09-21 | 美国倍利年制药有限公司 | 治疗或预防肥胖和体重管理的方法 |
CN114533653B (zh) * | 2020-11-26 | 2023-12-22 | 上海凯茂生物医药有限公司 | 一种人促红素杂合Fc融合蛋白相变型制剂及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5416979B2 (ja) * | 1972-01-08 | 1979-06-26 | ||
US4241099A (en) * | 1979-02-26 | 1980-12-23 | Tiemstra Peter J | Pectin formulations, products and methods having delayed-action acidulants |
US4789516A (en) * | 1983-04-15 | 1988-12-06 | Damon Biotech, Inc | Production of sustained released system |
US4690682A (en) * | 1983-04-15 | 1987-09-01 | Damon Biotech, Inc. | Sustained release |
US4744933A (en) * | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
CA1215922A (en) * | 1984-05-25 | 1986-12-30 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
JPS645460A (en) * | 1987-06-29 | 1989-01-10 | Sanei Kagaku Kogyo Kk | Production of delaying gelatinous material |
JPH0794583B2 (ja) * | 1989-12-15 | 1995-10-11 | 株式会社大塚製薬工場 | 高含水高分子ゲル |
IT1245383B (it) * | 1991-03-28 | 1994-09-20 | Eniricerche Spa | Composizione acquosa gelificabile avente tempo di gelificazione ritardato |
US5711968A (en) * | 1994-07-25 | 1998-01-27 | Alkermes Controlled Therapeutics, Inc. | Composition and method for the controlled release of metal cation-stabilized interferon |
KR960006730B1 (ko) * | 1993-02-11 | 1996-05-23 | 재단법인한국화학연구소 | 에멀젼 네트웍(emulsion network)을 이용한 약물의 피부 전달체계 |
GB9708773D0 (en) * | 1997-04-30 | 1997-06-25 | Reckitt & Colmann Prod Ltd | Organic compositions |
-
1998
- 1998-05-18 DE DE69838750T patent/DE69838750T2/de not_active Expired - Fee Related
- 1998-05-18 ES ES98922348T patent/ES2294814T3/es not_active Expired - Lifetime
- 1998-05-18 CA CA002289196A patent/CA2289196C/en not_active Expired - Fee Related
- 1998-05-18 PL PL336887A patent/PL199565B1/pl unknown
- 1998-05-18 BR BR9809117-4A patent/BR9809117A/pt not_active Application Discontinuation
- 1998-05-18 SK SK1543-99A patent/SK286437B6/sk not_active IP Right Cessation
- 1998-05-18 JP JP54960298A patent/JP2001525826A/ja not_active Ceased
- 1998-05-18 KR KR1019997010326A patent/KR20010012374A/ko not_active Application Discontinuation
- 1998-05-18 AU AU74918/98A patent/AU7491898A/en not_active Abandoned
- 1998-05-18 IL IL13281498A patent/IL132814A0/xx unknown
- 1998-05-18 EA EA199901013A patent/EA199901013A1/ru unknown
- 1998-05-18 YU YU58599A patent/YU58599A/sh unknown
- 1998-05-18 EP EP98922348A patent/EP0981374B1/en not_active Expired - Lifetime
- 1998-05-18 WO PCT/US1998/010013 patent/WO1998051348A2/en active IP Right Grant
- 1998-05-18 HU HU0003393A patent/HUP0003393A3/hu unknown
- 1998-05-18 CZ CZ0396399A patent/CZ299180B6/cs not_active IP Right Cessation
-
1999
- 1999-11-15 NO NO995591A patent/NO995591D0/no not_active Application Discontinuation
- 1999-11-23 BG BG103914A patent/BG64860B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
ES2294814T3 (es) | 2008-04-01 |
PL336887A1 (en) | 2000-07-17 |
AU7491898A (en) | 1998-12-08 |
NO995591L (no) | 1999-11-15 |
SK154399A3 (en) | 2000-07-11 |
DE69838750D1 (de) | 2008-01-03 |
PL199565B1 (pl) | 2008-10-31 |
HUP0003393A2 (hu) | 2001-02-28 |
KR20010012374A (ko) | 2001-02-15 |
NO995591D0 (no) | 1999-11-15 |
HUP0003393A3 (en) | 2001-03-28 |
CZ299180B6 (cs) | 2008-05-14 |
EP0981374B1 (en) | 2007-11-21 |
JP2001525826A (ja) | 2001-12-11 |
EP0981374A2 (en) | 2000-03-01 |
BR9809117A (pt) | 2000-08-01 |
DE69838750T2 (de) | 2008-10-30 |
EA199901013A1 (ru) | 2000-06-26 |
YU58599A (sh) | 2000-12-28 |
CA2289196C (en) | 2007-08-07 |
WO1998051348A2 (en) | 1998-11-19 |
BG103914A (en) | 2000-07-31 |
IL132814A0 (en) | 2001-03-19 |
BG64860B1 (bg) | 2006-07-31 |
CA2289196A1 (en) | 1998-11-19 |
CZ396399A3 (cs) | 2000-04-12 |
WO1998051348A3 (en) | 1999-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK286437B6 (sk) | Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie | |
US6656508B2 (en) | Sustained-release alginate gels | |
US20010007673A1 (en) | Sustained-release delayed gels | |
DE69933763T2 (de) | Biologisch abbaubares alginatgel mit verzögerter freisetzung | |
CA2433037C (en) | Sustained-release preparation | |
JP5160005B2 (ja) | 徐放性製剤 | |
EP1335661A2 (en) | Production of microspheres | |
US20100180464A1 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
AU2005200949B2 (en) | Sustained-Release Delayed Gels | |
MXPA99010284A (en) | Sustained-release delayed gels | |
CN1263472A (zh) | 缓释延迟凝胶剂 | |
KR100342746B1 (ko) | 인슐린의 방출제어제제 및 그 방법 | |
MXPA99009388A (en) | Sustained-release alginate gels | |
JP2001151694A (ja) | タンパク質粉体の製造法 | |
CZ20004111A3 (cs) | Biologicky odbouratelné alginátové gely s prodlouženým uvolňováním |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20090518 |